In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Immunology of Diabetes V

Edited by Edited by Carani B. Sanjeevi (Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden) and Desmond A. Schatz and Mark A. Atkinson (University of Florida College of Medicine, Gainesville, Florida)
Immunology of Diabetes V

Published: December 2008

Volume 1150

Learn More

Advances in diabetes research and treatment are presented, especially relating to type 1 diabetes, including autoantibody and cellular immune markers, animal models, the pancreas in type 1 diabetes, genetics of type 1 diabetes, the role of toll-like receptors and innate immunity, cell-based therapies, environmental and mechanistic causes of type 1 diabetes, mechanisms of beta-cell death, role of immune responses in type 1 diabetes, and islet transplantation.